Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-003381
Filing Date
2024-05-30
Accepted
2024-05-30 15:14:46
Documents
96
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q avrw_10q.htm   iXBRL 10-Q 853192
2 CERTIFICATION avrw_ex311.htm EX-31.1 9342
3 CERTIFICATION avrw_ex312.htm EX-31.2 10080
4 CERTIFICATION avrw_ex321.htm EX-32.1 4100
5 CERTIFICATION avrw_ex322.htm EX-32.2 4637
  Complete submission text file 0001477932-24-003381.txt   5513101

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA avrw-20240331.xsd EX-101.SCH 71729
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE avrw-20240331_lab.xml EX-101.LAB 332783
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avrw-20240331_cal.xml EX-101.CAL 58094
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avrw-20240331_pre.xml EX-101.PRE 292821
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avrw-20240331_def.xml EX-101.DEF 159766
100 EXTRACTED XBRL INSTANCE DOCUMENT avrw_10q_htm.xml XML 927107
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 241004390
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)